Verastem | VSTM - Ebitda





Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
AstraZeneca USD 5.67B 1.29B 2026-03
Curis USD -12.3M 231K 2023-09
Cytokinetics USD -169.32M 19.48M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
Incyte USD 367.97M 46.53M 2026-03
Laboratory Of America USD 605.6M 17.5M 2026-03
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
TG Therapeutics USD 51.69M 19M 2025-12